nascentbiotech.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.nascentbiotech.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Nascent Biotech, home of human antibody cancer product
Description Pritumumab is a proprietary monoclonal antibody (mAb) targeting a novel antigen on cancer cells. Nascent Biotech is the home of the natural human antibody cancer product Pritimumab, which has been shown to fight rare forms of cancer
Keywords N/A
Server Information
WebSite nascentbiotech faviconnascentbiotech.com
Host IP 209.182.193.252
Location United States
Related Websites
Site Rank
More to Explore
nascentbiotech.com Valuation
US$11,577,465
Last updated: 2023-05-01 19:08:41

nascentbiotech.com has Semrush global rank of 914,216. nascentbiotech.com has an estimated worth of US$ 11,577,465, based on its estimated Ads revenue. nascentbiotech.com receives approximately 1,335,862 unique visitors each day. Its web server is located in United States, with IP address 209.182.193.252. According to SiteAdvisor, nascentbiotech.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$11,577,465
Daily Ads Revenue US$10,687
Monthly Ads Revenue US$320,607
Yearly Ads Revenue US$3,847,281
Daily Unique Visitors 89,058
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
nascentbiotech.com. A 596 IP: 209.182.193.252
nascentbiotech.com. NS 3600 NS Record: ns73.domaincontrol.com.
nascentbiotech.com. NS 3600 NS Record: ns74.domaincontrol.com.
nascentbiotech.com. MX 3600 MX Record: 0 nascentbiotech-com.mail.protection.outlook.com.
nascentbiotech.com. TXT 3600 TXT Record: google-site-verification=u2m7r09MLeKeLPISVEksf3cZgQ160wxnevHScqsd6Zc
nascentbiotech.com. TXT 3600 TXT Record: NETORGFT7583048.onmicrosoft.com
nascentbiotech.com. TXT 3600 TXT Record: v=spf1 include:secureserver.net -all
HtmlToTextCheckTime:2023-05-01 19:08:41
Products Pritumumab CLNH5 MultiPharm Investors Corporate Governance Contact Investor Relations News About Corporate Management Board of Directors Science Advisory Board Contact Products Pritumumab CLNH5 MultiPharm Investors Corporate Governance Contact Investor Relations News About Corporate Management Board of Directors Science Advisory Board Contact Pritumumab is a proprietary monoclonal antibody (mAb) targeting a novel antigen on cancer cells. Pritumumab has received FDA orphan drug status NASCENT BIOTECH NEWS Nascent Submits Phase 2 Clinical Research Protocol to FDA for Review and Approval April 18, 2023 Corporate News , News , Press Releases , Science News NORTH PALM BEACH, FL / ACCESSWIRE / April 18, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage [...] 0 Nascent Announces the Completion of Its Phase 1 Clinical Trials February 28, 2023 Corporate News , Press Releases , Science News Nascent Completes Dosing Requirement
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx/1.21.3
Date: Sun, 24 Oct 2021 07:55:21 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Redirect-By: WordPress
Set-Cookie: __wpdm_client=9dc3afefb95b75c9465cfb125c16f5d5; HttpOnly
Location: https://nascentbiotech.com/
X-Proxy-Cache: DISABLED

HTTP/2 301 
server: nginx/1.21.3
date: Sun, 24 Oct 2021 07:55:22 GMT
content-type: text/html; charset=UTF-8
x-redirect-by: WordPress
set-cookie: __wpdm_client=9dc3afefb95b75c9465cfb125c16f5d5; secure; HttpOnly
location: https://www.nascentbiotech.com/
x-proxy-cache: DISABLED

HTTP/2 406 
server: nginx/1.21.3
date: Sun, 24 Oct 2021 07:55:24 GMT
content-type: text/html; charset=UTF-8
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
set-cookie: __wpdm_client=9dc3afefb95b75c9465cfb125c16f5d5; secure; HttpOnly
nascentbiotech.com Whois Information
Domain Name: NASCENTBIOTECH.COM
Registry Domain ID: 1849394114_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-03-07T17:55:13Z
Creation Date: 2014-03-06T17:29:54Z
Registry Expiry Date: 2022-03-06T17:29:54Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS73.DOMAINCONTROL.COM
Name Server: NS74.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-12T15:47:13Z <<<

Copyright © 2022 WebZZ.US 0.0228